Brazil authorizes world's first single-dose dengue vaccine
  • Nov 27, 2025

Brazil authorizes world's first single-dose dengue vaccine

  • CTV News
Doctors looking into hormone therapy as a way to ward off dementia in women
  • Nov 27, 2025

Doctors looking into hormone therapy as a way to ward off dementia in women

  • NBC News
U.S. Medicare cuts prices for 15 prescription drugs. Here's what they are
  • Nov 26, 2025

U.S. Medicare cuts prices for 15 prescription drugs. Here's what they are

  • Axios
Quantum BioPharma seeks $700M in 'stock spoofing' lawsuit
  • Nov 26, 2025

Quantum BioPharma seeks $700M in 'stock spoofing' lawsuit

  • CTV News
Premier promises Manitoban battling degenerative disease will get temporary coverage after outcry
  • Nov 26, 2025

Premier promises Manitoban battling degenerative disease will get temporary coverage after outcry

  • CBC News
Postpartum Prescription of GLP-1 Drugs Has Increased Sharply, Study Finds
  •  —
  • Nov 25, 2025

Postpartum Prescription of GLP-1 Drugs Has Increased Sharply, Study Finds

  • The New York Times
Family distraught as Manitoba maintains it won't pay for treatment for 30-year-old with degenerative disease
  • Nov 25, 2025

Family distraught as Manitoba maintains it won't pay for treatment for 30-year-old with degenerative disease

  • CBC News
People who stop using Mounjaro suffer reversal of health benefits, says study
  • Nov 24, 2025

People who stop using Mounjaro suffer reversal of health benefits, says study

  • The Guardian
Ozempic Drug Fails to Quell Alzheimer's in Novo Nordisk Trials
  •  —
  • Nov 24, 2025

Ozempic Drug Fails to Quell Alzheimer's in Novo Nordisk Trials

  • The New York Times
Zymeworks wanted to be Canada's first Big Pharma. Despite two blockbusters-in-the-making, that's no longer the plan
  •  —
  • Nov 24, 2025

Zymeworks wanted to be Canada's first Big Pharma. Despite two blockbusters-in-the-making, that's no longer the plan

  • The Globe and Mail
Eli Lilly joins the $1 trillion club
  • Nov 24, 2025

Eli Lilly joins the $1 trillion club

  • Axios
Doctors respond to US' 'data-free' decision over menopause hormone therapy: 'It's not true'
  • Nov 24, 2025

Doctors respond to US' 'data-free' decision over menopause hormone therapy: 'It's not true'

  • The Guardian
Pharmacare advisory committee says bilateral model is broken, calls for national essential-medicines list
  • Nov 23, 2025

Pharmacare advisory committee says bilateral model is broken, calls for national essential-medicines list

  • Canadian Press
Manitoban with degenerative disease urges province to cover life-sustaining drug after free coverage lapses
  • Nov 21, 2025

Manitoban with degenerative disease urges province to cover life-sustaining drug after free coverage lapses

  • CBC News
B.C. toddler travels to U.S. for potentially life-changing stem cell treatment
  • Nov 21, 2025

B.C. toddler travels to U.S. for potentially life-changing stem cell treatment

  • CTV News
Canada pharmacare report set to be made public
  • Nov 21, 2025

Canada pharmacare report set to be made public

  • CTV News
Health Canada approval backlog expected to push back arrival of generic Ozempic
  •  —
  • Nov 21, 2025

Health Canada approval backlog expected to push back arrival of generic Ozempic

  • The Globe and Mail
Denmark compensates patients for vision loss linked to semaglutide
  • Nov 21, 2025

Denmark compensates patients for vision loss linked to semaglutide

  • CTV News
The Trump administration is turning drug review into make-a-deal
  • Nov 21, 2025

The Trump administration is turning drug review into make-a-deal

  • STAT
Your doctor could be receiving payments from a drug company. Why won't anyone tell you?
  • Nov 20, 2025

Your doctor could be receiving payments from a drug company. Why won't anyone tell you?

  • Investigative Journalism Bureau
Millions of Kids Are on ADHD Pills. For Many, It’s the Start of a Drug Cascade.
  • Nov 20, 2025

Millions of Kids Are on ADHD Pills. For Many, It’s the Start of a Drug Cascade.

  • Wall Street Journal
New Gene-Editing Strategy Could Help Development of Treatments for Rare Diseases
  •  —
  • Nov 20, 2025

New Gene-Editing Strategy Could Help Development of Treatments for Rare Diseases

  • The New York Times
Infamous antidepressant drug trial back in spotlight after journal sued
  • Nov 19, 2025

Infamous antidepressant drug trial back in spotlight after journal sued

  • CTV News
Health Canada approves NILEMDO for the reduction of LDL-cholesterol in Canadians at Risk of CVD
  • Nov 18, 2025

Health Canada approves NILEMDO for the reduction of LDL-cholesterol in Canadians at Risk of CVD

  • CISION
Using AI to discover new drugs for fighting cancer and infectious disease
  • Nov 18, 2025

Using AI to discover new drugs for fighting cancer and infectious disease

  • University of Western Ontario
FDA's new warning on Sarepta raises more questions on heart risk
  • Nov 18, 2025

FDA's new warning on Sarepta raises more questions on heart risk

  • STAT
Judge to explain why he's approving Purdue Pharma settlement plan, which calls for $7B from Sacklers
  • Nov 18, 2025

Judge to explain why he's approving Purdue Pharma settlement plan, which calls for $7B from Sacklers

  • Associated Press
F.D.A. Sharply Limits Use of Drug Linked to Two Teen Deaths
  •  —
  • Nov 17, 2025

F.D.A. Sharply Limits Use of Drug Linked to Two Teen Deaths

  • The New York Times
Novo chops Wegovy prices, but doctors still see affordability challenges for patients
  • Nov 17, 2025

Novo chops Wegovy prices, but doctors still see affordability challenges for patients

  • Associated Press
Judge to Approve Purdue Pharma Bankruptcy, Releasing Billions for Opioid Plaintiffs
  •  —
  • Nov 14, 2025

Judge to Approve Purdue Pharma Bankruptcy, Releasing Billions for Opioid Plaintiffs

  • The New York Times
Lifelong drugs for autoimmune diseases don't work well. Now scientists are trying something new: CAR-T
  • Nov 14, 2025

Lifelong drugs for autoimmune diseases don't work well. Now scientists are trying something new: CAR-T

  • Associated Press
Why some people lose their hair when they’re on GLP-1s
  • Nov 14, 2025

Why some people lose their hair when they’re on GLP-1s

  • CTV News
Is getting a 'mismatched' flu shot still worth it? Yes, absolutely
  • Nov 13, 2025

Is getting a 'mismatched' flu shot still worth it? Yes, absolutely

  • CBC News
Health Canada won't explain $20M in pharmaceuticals lost from national stockpile
  • Nov 13, 2025

Health Canada won't explain $20M in pharmaceuticals lost from national stockpile

  • The Canadian Press
Inside Moderna’s rapid rise — and precarious future
  • Nov 13, 2025

Inside Moderna’s rapid rise — and precarious future

  • STAT
2 new malaria treatments show promise as drug resistance grows
  • Nov 13, 2025

2 new malaria treatments show promise as drug resistance grows

  • Associated Press
Biovac starts trials on South Africa's first domestically developed cholera vaccine
  • Nov 11, 2025

Biovac starts trials on South Africa's first domestically developed cholera vaccine

  • Associated Press
U.S. pushes drugmakers to reveal confidential details of contracts with Canada, other countries
  •  —
  • Nov 10, 2025

U.S. pushes drugmakers to reveal confidential details of contracts with Canada, other countries

  • The Globe and Mail
New website launching for adult cancer patients to find and join clinical trials
  •  —
  • Nov 10, 2025

New website launching for adult cancer patients to find and join clinical trials

  • The Globe and Mail
FDA removes decades-old warning on hormone therapy for menopause
  • Nov 10, 2025

FDA removes decades-old warning on hormone therapy for menopause

  • STAT
New Pill Could Slash Cholesterol Levels, Trials Suggest
  •  —
  • Nov 10, 2025

New Pill Could Slash Cholesterol Levels, Trials Suggest

  • The New York Times
India orders its drugmakers to meet global standards by January after cough syrup deaths
  • Nov 07, 2025

India orders its drugmakers to meet global standards by January after cough syrup deaths

  • CTV News

Get Canada’s essential briefing on health policy, science, and system change.  Get Briefing